Geode Capital Management, LLC Myovant Sciences Ltd. Transaction History

Geode Capital Management, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$24.03 - $27.02 $193,994 - $218,132	8,073 Added 2.04%	403,529 $10.9 Million
Q3 2022 Nov 14, 2022	SELL	$11.6 - $20.44 $267,542 - $471,428	-23,064 Reduced 5.51%	395,456 $7.1 Million
Q2 2022 Aug 12, 2022	BUY	$7.78 - $14.69 $207,617 - $392,017	26,686 Added 6.81%	418,520 $5.2 Million
Q1 2022 May 13, 2022	BUY	$11.38 - $16.4 $241,574 - $348,139	21,228 Added 5.73%	391,834 $5.22 Million
Q4 2021 Feb 11, 2022	BUY	$14.31 - $23.87 $125,928 - $210,056	8,800 Added 2.43%	370,606 $5.77 Million
Q3 2021 Nov 12, 2021	BUY	$18.94 - $26.99 $321,658 - $458,371	16,983 Added 4.93%	361,806 $8.12 Million
Q2 2021 Aug 13, 2021	BUY	$17.07 - $24.56 $206,615 - $297,274	12,104 Added 3.64%	344,823 $7.85 Million
Q1 2021 May 12, 2021	BUY	$20.46 - $25.18 $6.81 Million - $8.38 Million	332,719 New	332,719 $6.85 Million

61.3K

Ticker MYOV
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 96,802,800
Description
Myovant Sciences Ltd., a biopharmaceutical company, develops redefine care for women and for men. The company's lead product is relugolix, an oral, once-daily, small molecule that acts as a gonadotropin-releasing hormone receptor antagonist for the treatment of heavy menstrual bleeding related with uterine fibroids, endometriosis-associated pain...

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Geode Capital Management, LLC with notifications on news.